New Operation HOPE Research Finds That Financial Literacy Resources, Tools & Coaching Services Are Key Drivers of Optimism Despite Uncertain Economic Times
More than 3,500 HOPE Clients Responded to First-Ever Operation HOPE-Backed Survey, Providing Key Insights into a Broad Cross Section of American Financial Sentiment... Read more.
Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis
Data demonstrated effective control of intravascular and extravascular hemolysis through 48 weeks Results showed increase in mean hemoglobin levels were maintained... Read more.
MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
Pelabresib and ruxolitinib combination significantly reduced spleen size, with an SVR35 response rate nearly double that of placebo plus ruxolitinib Showed a strong... Read more.
Latest Data of InnoCare’s Oncology Pipelines Presented at the 65th Annual Meeting of ASH
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune... Read more.
New Data for Genentech’s Columvi and Lunsumio Presented at ASH 2023 Support Continued Benefit for People With Lymphoma
– Longer-term data from pivotal studies of fixed-duration Columvi and Lunsumio continue to show durable responses in people with heavily pre-treated lymphomas... Read more.
ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin Lymphoma
– 88% of patients with advanced stage classical Hodgkin Lymphoma in trial remained progression free at 24 months – – Investigational regimen that eliminates... Read more.
VINSSEN Co., Ltd. Successfully Supplies Hydrogen Fuel Cell for Industry Project in Singapore
Working with key industry partners to trial hydrogen as a marine fuel Successful factory inspection and delivery of hydrogen fuel cell for maritime auxiliary power... Read more.
FCA-Authorised Digital Asset Derivatives Venue GFO-X Raises $30m Series B Funding, Led by M&G Investments
M&G Investments is the £332 billion asset management arm of M&G plc Global Futures and Options Ltd (GFO-X), through its strategic partnership with LCH SA,... Read more.
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease
– Trial met its primary endpoint across all dose cohorts with 74% of patients at the 0.3 mg/kg dose achieving a complete or partial response within the first... Read more.
Morrow Sodali Acquires Australian Corporate Communication Consultancy, Domestique
Leading Global Stakeholder Engagement Advisory Firm Expands APAC Business, Advancing Strategy in Partnership with TPG SYDNEY–(BUSINESS WIRE)–Morrow Sodali... Read more.